📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. (2024)

First Author: Abhishek A

Attributed to: The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants. funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(23)00298-9

PubMed Identifier: 38267107

Publication URI: http://europepmc.org/abstract/MED/38267107

Type: Journal Article/Review

Volume: 6

Parent Publication: The Lancet. Rheumatology

Issue: 2

ISSN: 2665-9913